Gemzar and white blood cell count decreased Patient Reports February 13, 2012

Gemzar Side Effects Report #4642562-5
Gemzar side effect was reported by a Physician from on Apr 01, 2005. Male patient, 77 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, biliary tract infection, condition aggravated, decreased appetite, malignant neoplasm progression, pancreatic carcinoma stage iv, platelet count decreased, white blood cell count decreased. Gemzar dosage: 1000 MG/M2 OTHER. During the same period patient was treated with LOXONIN, SELBEX, LENDORM, URSODIOL, PURSENNID. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5566686-3
Gemzar side effect was reported by a Physician from JAPAN on Dec 13, 2007. Male patient, 75 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, jaundice , jaundice cholestatic, liver disorder, malignant neoplasm progression, platelet count decreased, white blood cell count decreased. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5129137-9
Gemzar side effect was reported by a Pharmacist from JAPAN on Sept 21, 2006. Male patient, 70 years of age, weighting 132.3 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, jaundice cholestatic, white blood cell count decreased. Gemzar dosage: 1000 MG/M^2, OTHER, INTRAVENOUS. During the same period patient was treated with OXYCONTIN, NOVAMIN, MAGNESIUM OXIDE. Patient recovered.

Gemzar Side Effects Report #5164650-X
Gemzar side effect was reported by a Physician from JAPAN on June 14, 2006. Male patient, 66 years of age, weighting 76.50 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: pulmonary tuberculosis, white blood cell count decreased. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with DECADRON #, NASEA. Patient was hospitalized. Patient recovered.


Gemzar Side Effects Report #5392247-5
Gemzar side effect was reported by a Physician from JAPAN on July 17, 2007. Male patient, 66 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: gastric perforation, gastric ulcer, malignant neoplasm progression, respiratory failure, white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with FLUOROURACIL, THERAPEUTIC RADIOPHARMACEUTICALS. Patient died on 09/13/2006.

Gemzar Side Effects Report #4692373-X
Gemzar side effect was reported by a Health Professional from on June 01, 2005. Female patient, 61 years of age, weighting 99.21 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood ph increased, interstitial lung disease, lung infiltration, malignant neoplasm progression, white blood cell count decreased. Gemzar dosage: 1400 MG OTHER. During the same period patient was treated with MS CONTIN, LOXONIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5993776-3
Gemzar side effect was reported by a Physician from JAPAN on Dec 09, 2008. Male patient, 57 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: neutrophil count decreased, septic shock, white blood cell count decreased. Gemzar dosage: 1200 MG, UNK. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5055322-0
Gemzar side effect was reported by a Physician from JAPAN on June 26, 2006. Female patient, 56 years of age, weighting 99.21 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, jaundice cholestatic, malignant neoplasm progression, metastases to liver, metastases to lymph nodes, pancreatic carcinoma recurrent, pancreatic carcinoma stage iv, white blood cell count decreased. Gemzar dosage: 1000 MG/M2, INTRAVENOUS. Patient recovered.

Gemzar Side Effects Report #4872593-1
Gemzar side effect was reported by a Physician from JAPAN on Dec 21, 2005. Female patient, 56 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: jaundice cholestatic, malignant neoplasm progression, metastases to liver, metastases to lymph nodes, pancreatic carcinoma, white blood cell count decreased. Gemzar dosage: 1000 MG/M2, OTHER, INTRAVENOUS. Patient recovered.


Gemzar Side Effects Report #5188598-X
Gemzar side effect was reported by a Physician from JAPAN on Dec 13, 2006. Male patient, 44 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: empyema, splenic abscess, white blood cell count decreased. Gemzar dosage: 800 MG, OTHER. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5606551-6
Gemzar side effect was reported by a Physician from JAPAN on Jan 16, 2008. Male patient, weighting 132.3 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, malnutrition, renal disorder, white blood cell count decreased. Gemzar dosage: 1600 MG, OTHER. During the same period patient was treated with DECADRON, KYTRIL, NEUTROGIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5618827-7
Gemzar side effect was reported by a Physician from JAPAN on Jan 25, 2008. Female patient was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: stevens-johnson syndrome, white blood cell count decreased. Gemzar dosage: 1500 MG, OTHER. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5638149-8
Gemzar side effect was reported by a Physician from JAPAN on Feb 14, 2008. Male patient, weighting 132.3 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, malnutrition, renal disorder, white blood cell count decreased. Gemzar dosage: 1600 MG, OTHER. During the same period patient was treated with DECADRON, KYTRIL, NEUTROGIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5774909-0
Gemzar side effect was reported by a Physician from JAPAN on June 06, 2008. Female patient was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, stevens-johnson syndrome, white blood cell count decreased. Gemzar dosage: 1500 MG, OTHER. Patient was hospitalized. Patient died.


Gemzar Side Effects Report #5891696-6
Gemzar side effect was reported by a Physician from JAPAN on June 06, 2008. Female patient was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, stevens-johnson syndrome, white blood cell count decreased. Gemzar dosage: 1500 MG, OTHER. Patient was hospitalized. Patient died.

Gemzar Side Effects Report #5935926-0
Gemzar side effect was reported by a Physician from JAPAN on Oct 21, 2008. Female patient, weighting 116.8 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis, gastric ulcer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: hepatic steatosis, white blood cell count decreased. Gemzar dosage: 1200 MG, OTHER. During the same period patient was treated with DEXART, RINDERON, NASEA, LANSOPRAZOLE. Patient recovered.

Gemzar Side Effects Report #6077718-0
Gemzar side effect was reported by a Physician from JAPAN on June 06, 2008. Female patient was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, stevens-johnson syndrome, white blood cell count decreased. Gemzar dosage: 1500 MG, OTHER. Patient was hospitalized. Patient died.

Gemzar Side Effects Report #6104012-1
Gemzar side effect was reported by a Physician from JAPAN on Mar 02, 2009. Female patient, weighting 105.8 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis against gastrointestinal ulcer, constipation , cancer pain and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, gastric ulcer haemorrhage, metastases to liver, platelet count decreased, shock haemorrhagic, white blood cell count decreased. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with PARIET, MAGMITT, FENTANYL, GASMOTIN. Patient died on 01/10/2009.

Gemzar Side Effects Report #5383221-3
Gemzar side effect was reported by a Physician from JAPAN on June 26, 2007. Male patient, 67 years of age, weighting 127.9 lb, was diagnosed with pancreatic carcinoma stage i and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cerebral infarction, flank pain, platelet count decreased, temporal lobe epilepsy, white blood cell count decreased. Gemzar dosage: 1700 MG, OTHER. During the same period patient was treated with DOGMATYL, MEILAX, NORVASC, CYANOCOBALAMIN, EVIPROSTAT, CARNACULIN. Patient recovered.


Gemzar Side Effects Report #5400681-X
Gemzar side effect was reported by a Physician from JAPAN on July 18, 2007. Male patient, 67 years of age, weighting 127.9 lb, was diagnosed with pancreatic carcinoma stage i and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cerebral infarction, flank pain, headache , platelet count decreased, white blood cell count decreased. Gemzar dosage: 1700 MG, OTHER. During the same period patient was treated with DOGMATYL, MEILAX, NORVASC, METHYCOBAL, EVIPROSTAT, CARNACULIN, FAMOTIDINE. Patient recovered.

Gemzar Side Effects Report #5418083-9
Gemzar side effect was reported by a Physician from JAPAN on Aug 08, 2007. Male patient, 68 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: diabetes mellitus, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Gemzar dosage: 800 MG, OTHER. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5391072-9
Gemzar side effect was reported by a Physician from JAPAN on July 11, 2007. Female patient, 67 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: jaundice , malaise, rash , stomatitis, white blood cell count decreased. Gemzar dosage: 1200 MG, OTHER. During the same period patient was treated with FLUOROURACIL, ISOVORIN, THERAPEUTIC RADIOPHARMACEUTICALS. Patient recovered.

Gemzar Side Effects Report #5533522-0
Gemzar side effect was reported by a Physician from JAPAN on Nov 28, 2007. Male patient, 54 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: accident at home, anorexia, stomatitis, tumour marker increased, white blood cell count decreased. Gemzar dosage: 1400 MG, OTHER. Patient died.

Gemzar Side Effects Report #5118118-7
Gemzar side effect was reported by a Health Professional from UNITED STATES on Sept 28, 2006. Female patient, 59 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal tenderness, colitis, escherichia infection, liver function test abnormal, neutropenia, urinary tract infection , white blood cell count decreased. Gemzar dosage: 1125 MILLIGRAM WEEKLY IV DRIP. During the same period patient was treated with TAXOTERE, XELODA, NEULASTA, GEMCITABINE, DOCETAXEL, SYNTHROID, ZETIA, NIASPAN. Patient was hospitalized. Patient recovered.


Gemzar Side Effects Report #4947464-2
Gemzar side effect was reported by a Physician from JAPAN on Feb 27, 2006. Male patient, 79 years of age, weighting 117.7 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, depressed level of consciousness, hepatic failure, hepatic necrosis, international normalised ratio increased, liver disorder, melaena, white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS, URSO. Patient died on 10/14/2005.

Gemzar Side Effects Report #4991159-6
Gemzar side effect was reported by a Health Professional from JAPAN on Apr 18, 2006. Male patient, 78 years of age, weighting 125.7 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, pneumonitis, white blood cell count decreased. Gemzar dosage: 1600 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5002811-0
Gemzar side effect was reported by a Physician from JAPAN on Apr 28, 2006. Male patient, 78 years of age, weighting 125.7 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: c-reactive protein increased, haemoglobin decreased, pneumonitis, pyrexia, white blood cell count decreased. Gemzar dosage: 1600 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5521170-8
Gemzar side effect was reported by a Physician from JAPAN on Nov 07, 2007. Male patient, 75 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, jaundice , jaundice cholestatic, liver disorder, malignant neoplasm progression, platelet count decreased, white blood cell count decreased. Gemzar dosage: unknown. Patient recovered.

Gemzar Side Effects Report #4705316-7
Gemzar side effect was reported by a Physician from on June 13, 2005. Male patient, 74 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: neutrophil percentage increased, pneumonia , septic shock, white blood cell count decreased. Gemzar dosage: 1200 MG OTHER. Patient recovered.


Gemzar Side Effects Report #6114848-9
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on May 08, 2008. Male patient, 71 years of age, weighting 197.1 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: decreased appetite, dysgeusia, oral candidiasis, pyrexia, white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with CAPECITABINE, DOCETAXEL. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5485631-2
Gemzar side effect was reported by a Physician from JAPAN on Oct 01, 2007. Male patient, 68 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, diabetes mellitus, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Gemzar dosage: 800 MG, OTHER. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5486380-7
Gemzar side effect was reported by a Physician from JAPAN on Oct 01, 2007. Male patient, 68 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: diabetes mellitus, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Gemzar dosage: 800 MG, OTHER. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5579333-1
Gemzar side effect was reported by a Physician from JAPAN on Dec 19, 2007. Male patient, 68 years of age, weighting 127.9 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, diabetes mellitus, malignant neoplasm progression, thrombocytopenia, white blood cell count decreased. Gemzar dosage: 1000 MG, WEEKLY(1/W). During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4596044-X
Gemzar side effect was reported by a Health Professional from on Feb 07, 2005. Male patient, 64 years of age, weighting 88.18 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, neutrophil count decreased, pyothorax, staphylococcal infection , white blood cell count decreased. Gemzar dosage: 1000 MG OTHER. During the same period patient was treated with COSPANON, URSODIOL, MS CONTIN. Patient was hospitalized. Patient recovered.


Gemzar Side Effects Report #4681976-4
Gemzar side effect was reported by a Physician from on May 16, 2005. Male patient, 64 years of age, weighting 88.18 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, disease recurrence, pyothorax, pyrexia, staphylococcal infection , white blood cell count decreased. Gemzar dosage: 1000 MG OTHER. During the same period patient was treated with COSPANON, URSODIOL, MS CONTIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4546605-9
Gemzar side effect was reported by a Physician from on Dec 14, 2004. Female patient, 62 years of age, weighting 103.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haemoglobin decreased, hepatic failure, malignant neoplasm progression, metastases to liver, neutrophil count decreased, white blood cell count decreased. Gemzar dosage: 210 MG OTHER. During the same period patient was treated with VOLTARENE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5383234-1
Gemzar side effect was reported by a Physician from JAPAN on June 29, 2007. Male patient, 59 years of age, weighting 109.3 lb, was diagnosed with pancreatic carcinoma, prophylaxis against gastrointestinal ulcer, back pain , constipation , dyspepsia, prophylaxis of nausea and vomiting and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain lower, decreased appetite, hepatic function abnormal, malaise, neutrophil count decreased, platelet count decreased, pyrexia, white blood cell count decreased. Gemzar dosage: 1400 MG, OTHER. During the same period patient was treated with GASTER D, SELTOUCH, MAGLAX, PURSENNID, BERIZYM, NASEA, KYTRIL. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4611179-0
Gemzar side effect was reported by a Health Professional from on Apr 20, 2004. Male patient, 58 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: pneumonitis, white blood cell count decreased. Gemzar dosage: 2220 MG. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5447359-4
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 05, 2007. Female patient, weighting 163.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, dyspnoea exertional, white blood cell count decreased. Gemzar dosage: 1327 MG WKLYX3WKS IV. During the same period patient was treated with CETUXIMAB. Patient was hospitalized. Patient recovered.


Gemzar Side Effects Report #5605905-1
Gemzar side effect was reported by a Physician from JAPAN on Jan 16, 2008. Male patient, weighting 138.9 lb, was diagnosed with pancreatic carcinoma, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood calcium decreased, cardiac failure congestive, haemoglobin decreased, neutrophil count decreased, oedema, pleural effusion, white blood cell count decreased. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with BERIZYM, GASMOTIN, URSO, GASTER D, LAC B, LEUCON, CEPHARANTHIN, NEUPOGEN. Patient recovered.

Gemzar Side Effects Report #5638165-6
Gemzar side effect was reported by a Physician from JAPAN on Feb 14, 2008. Male patient, weighting 138.9 lb, was diagnosed with pancreatic carcinoma, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood calcium decreased, cardiac failure congestive, haemoglobin decreased, neutrophil count decreased, white blood cell count decreased. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with BERIZYM, GASMOTIN, URSO, GASTER D, LAC B, LEUCON, CEPHARANTHIN, NEUPOGEN. Patient recovered.

Gemzar Side Effects Report #5786059-8
Gemzar side effect was reported by a Physician from JAPAN on June 12, 2008. Female patient was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, platelet count decreased, renal failure, white blood cell count decreased. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with PROTECADIN, WARFARIN, URSO, LOXONIN, STARSIS, PRIMPERAN, ZOFRAN. Patient died on 11/04/2007.

Gemzar Side Effects Report #6085635-5
Gemzar side effect was reported by a Physician from JAPAN on Feb 18, 2009. Female patient was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, no therapeutic response, renal failure, white blood cell count decreased. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with PROTECADIN, WARFARIN, URSO, LOXONIN, STARSIS, PRIMPERAN, ZOFRAN. Patient died on 11/04/2007.

Gemzar Side Effects Report #4937435-4
Gemzar side effect was reported by a Pharmacist from JAPAN on Feb 14, 2006. Female patient was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: gallbladder perforation, white blood cell count decreased. Gemzar dosage: 1400 MG, OTHER, INTRAVENOUS. Patient recovered.

Gemzar Side Effects Report #6115114-8
Gemzar side effect was reported by a Pharmacist from UNITED STATES on July 22, 2008. Female patient, 59 years of age, was diagnosed with ovarian epithelial cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: influenza like illness, pyrexia, white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient recovered.

Gemzar Side Effects Report #4992784-9
Gemzar side effect was reported by a Health Professional from UNITED STATES on May 31, 2005. Female patient, 63 years of age, weighting 211.4 lb, was diagnosed with ovarian epithelial cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: febrile neutropenia, hypokalaemia, vaginal haemorrhage, white blood cell count decreased. Gemzar dosage: 1400 MG,. During the same period patient was treated with CARBOPLATIN, PROCRIT. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4735285-5
Gemzar side effect was reported by a Physician from UNITED STATES on July 19, 2005. Female patient, 88 years of age, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac disorder, chest pain , dyspnoea, hypertension, ischaemia, platelet count decreased, white blood cell count decreased. Gemzar dosage: 1190 MG. During the same period patient was treated with TAXOL, CARBOPLATIN, TAXOTERE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4737431-6
Gemzar side effect was reported by a Physician from UNITED STATES on July 19, 2005. Female patient, 88 years of age, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac disorder, chest pain , dyspnoea, hypertension, ischaemia, platelet count decreased, white blood cell count decreased. Gemzar dosage: 1190 MG. During the same period patient was treated with TAXOL, CARBOPLATIN, TAXOTERE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4714603-8
Gemzar side effect was reported by a Health Professional from UNITED STATES on July 14, 2005. Female patient, 74 years of age, weighting 145.5 lb, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: chills, feeling abnormal, haemoglobin decreased, neutropenia, platelet count decreased, pyrexia, white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.


Gemzar Side Effects Report #4639999-7
Gemzar side effect was reported by a Physician from on Mar 30, 2005. Female patient, 50 years of age, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: asthenia, febrile neutropenia, loss of consciousness, white blood cell count decreased. Gemzar dosage: 800 MG/M2 OTHER. During the same period patient was treated with DOCETAXEL. Patient died on 03/26/2005.

Gemzar Side Effects Report #5337639-5
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 02, 2006. Female patient, 46 years of age, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: herpes zoster, rash pruritic, white blood cell count decreased. Gemzar dosage: 1800 MG, INTRAVENOUS. During the same period patient was treated with KYTRIL, BENDARYL, DEXAMETHASONE, PEPCID. Patient recovered.

Gemzar Side Effects Report #4655325-1
Gemzar side effect was reported by a Health Professional from on Apr 15, 2005. Male patient, 73 years of age, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: asthenia, coombs positive haemolytic anaemia, gastrointestinal haemorrhage, platelet count decreased, procedural complication, white blood cell count decreased. Gemzar dosage: 200 MG/M2. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5337434-7
Gemzar side effect was reported by a Physician from UNITED STATES on Sept 25, 2006. Female patient, 62 years of age, weighting 121.9 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Gemzar dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, PREDNISONE, PREVACID, PROCHLORPERAZINE MALEATE, TRAMADOL, PERSANTINE, PREGABALIN. Patient recovered.

Gemzar Side Effects Report #5087095-X
Gemzar side effect was reported by a Health Professional from TURKEY on Aug 01, 2006. Male patient, 61 years of age, weighting 154.3 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bone marrow toxicity, dyspnoea, haemoglobin decreased, loss of consciousness, neutrophil percentage decreased, platelet count decreased, white blood cell count decreased. Gemzar dosage: 1800 MG, OTHER, INTRAVENOUS. During the same period patient was treated with CISPLATIN, ANTIEMETICS AND ANTINAUSEANTS, ANTIHISTAMINES, CORTICOSTEROIDS. Patient was hospitalized. Patient died on 03/11/2004.

Gemzar Side Effects Report #4853514-4
Gemzar side effect was reported by a Physician from JAPAN on Nov 24, 2005. Female patient, 59 years of age, weighting 97.00 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anorexia, c-reactive protein increased, platelet count decreased, pneumonia , pyrexia, white blood cell count decreased. Gemzar dosage: 1300 MG, OTHER, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, ORGADRONE, NASEA. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4797314-2
Gemzar side effect was reported by a Physician from UNITED STATES on July 28, 2005. Male patient, 70 years of age, weighting 213.8 lb, was diagnosed with non-small cell lung cancer stage iiib and was treated with Gemzar. After drug was administered, patient experienced the following side effects: fatigue, haemoptysis, international normalised ratio increased, red blood cell count decreased, superior vena caval occlusion, vomiting, white blood cell count decreased. Gemzar dosage: 1760 MG. During the same period patient was treated with ALIMTA, OMNICEF, CARBOPLATIN, COUMADIN, FOLIC ACID, VITAMIN B, COMPAZINE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5646915-8
Gemzar side effect was reported by a Physician from UNITED STATES on Feb 24, 2008. Male patient, 75 years of age, weighting 185.0 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, dyspnoea, platelet count decreased, pneumonia , white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with TARCEVA, INSPRA, COREG, DIABETA, ZOCOR. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5337810-2
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 11, 2006. Male patient, 74 years of age, weighting 179.9 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, dyspnoea, haemoglobin decreased, platelet count decreased, platelet count increased, pulmonary toxicity, white blood cell count decreased, white blood cell count increased. Gemzar dosage: unknown. Patient recovered.

Gemzar Side Effects Report #4992605-4
Gemzar side effect was reported by a Health Professional from UNITED STATES on Jan 11, 2006. Male patient, 74 years of age, weighting 179.9 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, dyspnoea, haematocrit decreased, haemoglobin decreased, platelet count decreased, platelet count increased, pulmonary toxicity, white blood cell count decreased, white blood cell count increased. Gemzar dosage: 1800 MG. Patient recovered.


Gemzar Side Effects Report #6115275-0
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 29, 2008. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood count abnormal, haemoglobin decreased, lacrimation increased, ocular hyperaemia, paraesthesia, platelet count decreased, vomiting, white blood cell count decreased. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with NEXIUM, ANTIHYPERTENSIVES. Patient recovered.

Gemzar Side Effects Report #4971463-8
Gemzar side effect was reported by a Physician from JAPAN on Mar 23, 2006. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, disseminated intravascular coagulation, malignant ascites, malignant neoplasm progression, non-small cell lung cancer, septic shock, white blood cell count decreased. Gemzar dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with OXYCONTIN. Patient died on 12/11/2005.

Gemzar Side Effects Report #4579432-7
Gemzar side effect was reported by a Physician from on Jan 24, 2005. Female patient, 69 years of age, weighting 191.8 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, platelet count decreased, pruritus, stridor, white blood cell count decreased. Gemzar dosage: 1600 MG. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4799893-8
Gemzar side effect was reported by a Physician from JAPAN on Sept 28, 2005. Male patient, 66 years of age, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: platelet count decreased, pneumonia , white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN. Patient died on 09/21/2005.

Gemzar Side Effects Report #4806816-1
Gemzar side effect was reported by a Physician from CHINA on Sept 28, 2005. Male patient, 66 years of age, weighting 149.9 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: platelet count decreased, pneumonia , pulmonary haemorrhage, respiratory failure, white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN, CARBOPLATIN, CEFOPERAZONE W. Patient died on 09/21/2005.

Gemzar Side Effects Report #4814950-5
Gemzar side effect was reported by a Physician from CHINA on Oct 11, 2005. Male patient, 66 years of age, weighting 149.9 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: platelet count decreased, pneumonia , pulmonary haemorrhage, respiratory failure, white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN, CARBOPLATIN, CEFOPERAZONE W. Patient died on 09/21/2005.

Gemzar Side Effects Report #4611055-3
Gemzar side effect was reported by a Health Professional from on Apr 02, 2004. Male patient, 67 years of age, weighting 143.3 lb, was diagnosed with metastatic carcinoma of the bladder and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain , anorexia, fatigue, malignant neoplasm progression, white blood cell count decreased. Gemzar dosage: 1380 MG OTHER. During the same period patient was treated with TAXOL, KYTRIL, DECADRON, BENADRYL, TAGAMET, ARANESP. Patient died on 01/01/2004.

Gemzar Side Effects Report #5113928-4
Gemzar side effect was reported by a Pharmacist from JAPAN on Aug 31, 2006. Male patient, 62 years of age, weighting 142.2 lb, was diagnosed with lung squamous cell carcinoma recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain upper, decreased appetite, malaise, oesophageal candidiasis, reflux oesophagitis, white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with NAVELBINE, THERAPEUTIC RADIOPHARMACEUTICALS, KYTRIL, SULFAMETHOXAZOLE, PREDNISOLONE, FAMOTIDINE, CLARITHROMYCIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5140596-8
Gemzar side effect was reported by a Pharmacist from JAPAN on Oct 05, 2006. Male patient, 62 years of age, weighting 142.2 lb, was diagnosed with lung squamous cell carcinoma recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain upper, decreased appetite, malaise, oesophageal candidiasis, reflux oesophagitis, white blood cell count decreased. Gemzar dosage: 1700 MG OTHER INTRAVENOUS. During the same period patient was treated with NAVELBINE, THERAPEUTIC RADIOPHARMACEUTICALS, KYTRIL, SULFAMETHOXAZOLE, PREDNISOLONE, FAMOTIDINE, CLARITHROMYCIN, ADONA. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4611092-9
Gemzar side effect was reported by a Pharmacist from on Nov 08, 2004. Male patient, 79 years of age, weighting 187.4 lb, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: chills, dementia , haemoglobin decreased, pyrexia, red blood cell count decreased, white blood cell count decreased. Gemzar dosage: 2060 MG. During the same period patient was treated with ASPIRIN, DILTIAZEM, LESCOL, ATROVENT, SAW PALMETTO, PRANDIN, SEREVENT. Patient was hospitalized. Patient recovered.


Gemzar Side Effects Report #5106947-5
Gemzar side effect was reported by a Pharmacist from JAPAN on Aug 24, 2006. Female patient, 62 years of age, weighting 141.1 lb, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain , abdominal symptom, anorexia, oesophageal candidiasis, reflux oesophagitis, white blood cell count decreased. Gemzar dosage: 1700 MG, OTHER, INTRAVENOUS. During the same period patient was treated with NAVELBINE, KYTRIL, SULFAMETHOXAZOLE, PREDNISOLONE, FAMOTIDINE, CLARITHROMYCIN, ADONA, TRANSAMIN. Patient recovered.

Gemzar Side Effects Report #4947491-5
Gemzar side effect was reported by a Consumer or non-health professional from FRANCE on Feb 27, 2006. Female patient, 65 years of age, was diagnosed with lung neoplasm and was treated with Gemzar. After drug was administered, patient experienced the following side effects: neutropenia, purpura, pyrexia, thrombocytopenia, toxic skin eruption, white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5278039-6
Gemzar side effect was reported by a Consumer or non-health professional from BRAZIL on Mar 19, 2007. Female patient, 67 years of age, was diagnosed with lung cancer metastatic, lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bone cancer metastatic, bone pain, brain cancer metastatic, platelet count decreased, pyrexia, white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with DEXAMETHASONE, NAUSEDRON. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5239751-8
Gemzar side effect was reported by a Physician from JAPAN on Feb 06, 2007. Female patient, 77 years of age, weighting 146.6 lb, was diagnosed with lung adenocarcinoma stage iv, hypertension, hyperlipidaemia, cough, asthma , insomnia and was treated with Gemzar. After drug was administered, patient experienced the following side effects: constipation , deep vein thrombosis , malaise, pulmonary embolism , white blood cell count decreased. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with NAVELBINE, DIOVAN, NORVASC, LIPITOR, MUCODYNE, SINGULAIR, LENDORMIN, HOKUNALIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5241755-6
Gemzar side effect was reported by a Physician from JAPAN on Feb 14, 2007. Female patient, 77 years of age, weighting 146.6 lb, was diagnosed with lung adenocarcinoma stage iv, hypertension, hyperlipidaemia, cough, asthma , insomnia and was treated with Gemzar. After drug was administered, patient experienced the following side effects: constipation , deep vein thrombosis , malaise, pulmonary embolism , white blood cell count decreased. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with NAVELBINE, DIOVAN, NORVASC, LIPITOR, MUCODYNE, SINGULAIR, LENDORMIN, HOKUNALIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4824472-3
Gemzar side effect was reported by a Physician from JAPAN on Oct 24, 2005. Female patient, 31 years of age, weighting 114.6 lb, was diagnosed with lung adenocarcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: nausea , nephrotic syndrome, white blood cell count decreased. Gemzar dosage: 1500 MG OTHER. During the same period patient was treated with CISPLATIN. Patient recovered.

Gemzar Side Effects Report #4992793-X
Gemzar side effect was reported by a Physician from UNITED STATES on Oct 28, 2005. Male patient, 60 years of age, was diagnosed with gastric cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: platelet count decreased, white blood cell count decreased. Gemzar dosage: 1600 MG. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5071768-9
Gemzar side effect was reported by a Physician from JAPAN on July 24, 2006. Male patient, 50 years of age, weighting 130.1 lb, was diagnosed with gallbladder cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: portal vein thrombosis, white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS, URSO, ZANTAC. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5016825-8
Gemzar side effect was reported by a Physician from JAPAN on May 10, 2006. Male patient, 50 years of age, was diagnosed with gallbladder cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cholecystectomy, choledochectomy, lymphadenectomy, lymphadenopathy, necrosis, portal vein thrombosis, white blood cell count decreased. Gemzar dosage: 330 MG, OTHER, INTRAVENOUS. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS. Patient recovered.

Gemzar Side Effects Report #5024874-9
Gemzar side effect was reported by a Physician from JAPAN on May 24, 2006. Male patient, 50 years of age, was diagnosed with gallbladder cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: necrosis, portal vein thrombosis, white blood cell count decreased. Gemzar dosage: 330 MG, OTHER, INTRAVENOUS. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS. Patient recovered.


Gemzar Side Effects Report #5034723-0
Gemzar side effect was reported by a Physician from JAPAN on June 05, 2006. Male patient, 50 years of age, weighting 130.1 lb, was diagnosed with gallbladder cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: portal vein thrombosis, white blood cell count decreased. Gemzar dosage: 330 MG, OTHER, INTRAVENOUS; SEE IMAGE. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS, URSO, ZANTAC. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5520491-2
Gemzar side effect was reported by a Physician from JAPAN on Nov 06, 2007. Female patient, weighting 106.9 lb, was diagnosed with gallbladder cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood albumin decreased, haemoglobin decreased, hepatic function abnormal, malignant neoplasm progression, neutrophil count decreased, platelet count decreased, po2 decreased, white blood cell count decreased. Gemzar dosage: 1400 MG, OTHER. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4638161-1
Gemzar side effect was reported by a Physician from on Mar 24, 2005. Female patient, 56 years of age, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, granulocyte count decreased, haemolytic anaemia, red blood cell schistocytes present, thrombocytopenia, thrombotic thrombocytopenic purpura, white blood cell count decreased. Gemzar dosage: 2670 MG. During the same period patient was treated with CALCIUM GLUCONATE, COUMADIN, OMEGA, AMBIEN, PROTONIX, FLEXERIL, LEXAPRO. Patient recovered.

Gemzar Side Effects Report #4871043-9
Gemzar side effect was reported by a Consumer or non-health professional from TURKEY on Dec 19, 2005. Female patient, 48 years of age, weighting 127.9 lb, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: erythema, platelet count decreased, stomatitis, white blood cell count decreased. Gemzar dosage: 1000 MG/M2, INTRAVENOUS. During the same period patient was treated with DOXETAXEL. Patient recovered.

Gemzar Side Effects Report #4876153-8
Gemzar side effect was reported by a Health Professional from TURKEY on Dec 28, 2005. Female patient, 48 years of age, weighting 127.9 lb, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: erythema, platelet count decreased, stomatitis, white blood cell count decreased. Gemzar dosage: 1000 MG/M2, INTRAVENOUS. During the same period patient was treated with DOCETAXEL. Patient recovered.

Gemzar Side Effects Report #4891954-8
Gemzar side effect was reported by a Physician from GERMANY on Jan 10, 2006. Female patient, 62 years of age, was diagnosed with breast cancer  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: coordination abnormal, diplopia, dizziness , polyneuropathy, vith nerve paralysis, white blood cell count decreased. Gemzar dosage: 1000 MG, INTRAVENOUS. During the same period patient was treated with ZOMETA. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5675430-0
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 22, 2007. Male patient, 78 years of age, was diagnosed with bladder cancer  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: thrombocytopenia, white blood cell count decreased. Gemzar dosage: 1000 MG, INTRAVENOUS. Patient recovered.

Gemzar Side Effects Report #6027094-4
Gemzar side effect was reported by a Physician from JAPAN on Dec 25, 2008. Male patient, weighting 138.2 lb, was diagnosed with bile duct cancer stage i, hypertension, hyperlipidaemia, prophylaxis, constipation  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, platelet count decreased, pyrexia, retinal haemorrhage, white blood cell count decreased. Gemzar dosage: 1000 MG, UNK. During the same period patient was treated with DIOVAN, ARTIST, MEVALOTIN, ASPIRIN, ALOSITOL, MAGNESIUM OXIDE, PURSENNID. Patient recovered.

Gemzar Side Effects Report #4937404-4
Gemzar side effect was reported by a Consumer or non-health professional from GERMANY on Feb 14, 2006. Male patient, 69 years of age, weighting 176.4 lb, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pyrexia, thrombophlebitis, white blood cell count decreased. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4655998-3
Gemzar side effect was reported by a Physician from on Apr 19, 2005. Male patient, 60 years of age, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain upper, chills, fatigue, pyrexia, white blood cell count decreased. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with PARACETAMOL. Patient recovered.

Gemzar Side Effects Report #5092012-2
Gemzar side effect was reported by a Physician from JAPAN on Aug 10, 2006. Male patient, 56 years of age, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, platelet count increased, white blood cell count decreased. Gemzar dosage: 1000 MG/M2, UNK, INTRAVENOUS. Patient recovered.

Gemzar Side Effects Report #5407367-6
Gemzar side effect was reported by a Physician from JAPAN on July 25, 2007. Male patient, 55 years of age, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anorexia, lung neoplasm, malignant neoplasm progression, stomatitis, white blood cell count decreased. Gemzar dosage: 1700 MG, OTHER. Patient recovered.

Gemzar Side Effects Report #4806761-1
Gemzar side effect was reported by a Physician from JAPAN on Oct 05, 2005. Male patient, 55 years of age, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cholangitis acute, platelet count decreased, white blood cell count decreased. Gemzar dosage: 1000 MG/M2 OTHER. During the same period patient was treated with TEGAFUR. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5731701-0
Gemzar side effect was reported by a Physician from JAPAN on May 01, 2008. Male patient, weighting 145.5 lb, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: erythema, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Gemzar dosage: 1600 MG, UNK. During the same period patient was treated with DEPAKENE, CALONAL, LOXONIN, ALDACTONE, LANSOPRAZOLE, URSO, TAURINE. Patient died on 03/24/2008.

Gemzar Side Effects Report #5869757-7
Gemzar side effect was reported by a Physician from JAPAN on Aug 20, 2008. Male patient, weighting 145.5 lb, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: erythema, haemoglobin decreased, malignant neoplasm progression, oedema peripheral, platelet count decreased, white blood cell count decreased. Gemzar dosage: 1600 MG, UNK. During the same period patient was treated with DEPAKENE, ACETAMINOPHEN, LOXONIN, ALDACTONE, LANSOPRAZOLE, URSO, TAURINE. Patient died on 03/24/2008.

Gemzar Side Effects Report #4791724-5
Gemzar side effect was reported by a Physician from JAPAN on Sept 21, 2005. Female patient, 68 years of age, was diagnosed with adenocarcinoma pancreas and was treated with Gemzar. After drug was administered, patient experienced the following side effects: eyelid oedema, neutrophil count decreased, pharyngeal oedema, pyrexia, white blood cell count decreased. Gemzar dosage: 1000 MG OTHER. Patient recovered.

Gemzar Side Effects Report #5521180-0
Gemzar side effect was reported by a Physician from JAPAN on Nov 07, 2007. Male patient, 55 years of age, was diagnosed with adenocarcinoma pancreas and was treated with Gemzar. After drug was administered, patient experienced the following side effects: intestinal obstruction, white blood cell count decreased. Gemzar dosage: 200 MG, OTHER. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5337407-4
Gemzar side effect was reported by a Physician from UNITED STATES on June 06, 2006. Female patient, 42 years of age, was diagnosed with adenocarcinoma pancreas and was treated with Gemzar. After drug was administered, patient experienced the following side effects: conjunctival haemorrhage, diarrhoea, mucosal inflammation, platelet count decreased, white blood cell count decreased. Gemzar dosage: 350 MG/M2, INTRAVENOUS. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS. Patient recovered.

Gemzar Side Effects Report #5155051-9
Gemzar side effect was reported by a Physician from JAPAN on Oct 27, 2006. Female patient, 68 years of age, was diagnosed with adenocarcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: malignant ascites, malignant neoplasm progression, metastases to bone, metastases to lung, neck pain, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Gemzar dosage: 1000 MG/M2, OTHER. Patient was hospitalized. Patient died on 09/13/2003.

Gemzar Side Effects Report #5308195-2
Gemzar side effect was reported by a Physician from JAPAN on Apr 17, 2007. Male patient, 74 years of age, weighting 121.3 lb, was diagnosed with depression , dyspnoea, insomnia, prophylaxis against gastrointestinal ulcer, back pain , gastritis prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease, malignant neoplasm progression, metastases to central nervous system, platelet count decreased, pneumonia , pyrexia, respiratory failure, white blood cell count decreased. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with NAVALBINE, MEILAX, PREDONINE, SOLANAX, GASTER D, LOXONIN, SELBEX. Patient was hospitalized. Patient died on 01/05/2007.